Sickle cell disease (SCD) is a genetic blood disorder that affects the production of hemoglobin, a protein in red blood cells that carries oxygen throughout the body. SCD can cause severe pain episodes, anemia, organ damage, and a shortened life expectancy.

Recent studies have suggested that medicinal cannabis may be beneficial in managing the symptoms of SCD. A 2020 study published in the journal “Cannabis and Cannabinoid Research” found that medical marijuana use was associated with a reduction in pain and opioid use in patients with SCD. Another study published in “Clinical and Experimental Rheumatology” in 2021 showed that medical cannabis use was associated with reduced inflammation and improved quality of life in SCD patients.

Medicinal marijuana may also help manage the anxiety and depression that often accompany SCD. A 2021 study published in the “Journal of Pain Research” found that medicinal cannabis use was associated with reduced anxiety and depression in patients with chronic pain.

It is important to note that medical cannabis should not be used as a substitute for standard treatments for SCD. However, for patients who are not finding relief with traditional treatments, medical marijuana may be a viable option.

If you or anyone you know is interested in starting the medical marijuana certification process for symptom relief, consult a physician today.